Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-03, Stock:ABBV, The news for the past five days is as follows:
2019-06-26: NEWS1: Is Allergan a Good Deal for AbbVie?.NEWS2: AbbVie Rebounds as Market Warms to Allergan Deal, Botox Potential.NEWS3: AbbVie Is 'The New Cash King' As It Takes On Botox-Maker Allergan.NEWS4: Morphic Holding IPO: What You Need To Know.NEWS5: Wednesday’s Vital Data: AbbVie, FedEx and Micron.NEWS6: Wednesday’s Vital Data: AbbVie, FedEx and Micron.NEWS7: AbbVie to Buy Allergan: Prescribed ETFs.NEWS8: AbbVie to Buy Allergan: Prescribed ETFs.NEWS9: Elliott Management Advocated for an Allergan Split Prior to Sale.NEWS10: Company News For Jun 26, 2019.NEWS11: Company News For Jun 26, 2019.NEWS12: 3 Big Stock Charts for Wednesday: Tyson Foods, Lennar and State Street.NEWS13: 3 Big Stock Charts for Wednesday: Tyson Foods, Lennar and State Street.NEWS14: The Zacks Analyst Blog Highlights: AbbVie, Allergan, Bristol-Myers and Celgene.NEWS15: The Zacks Analyst Blog Highlights: AbbVie, Allergan, Bristol-Myers and Celgene.NEWS16: AbbVie to Acquire Allergan in Nearly $62B Cash & Stock Deal.NEWS17: AbbVie to Acquire Allergan in Nearly $62B Cash & Stock Deal.NEWS18: Here's Why Nobody's Happy About This $63 Billion Buyout.NEWS19: Here's Why Nobody's Happy About This $63 Billion Buyout.NEWS20: Big Pharma Has to Bet Big on M&A. Investors Don’t..NEWS21: AbbVie to Buy Allergan: Prescribed ETFs.NEWS22: AbbVie's $63 billion Allergan deal shakes up big pharma.NEWS23: Company News For Jun 26, 2019.NEWS24: Health Care Sector Update for 06/26/2019: ACST, ABBV, EYEG, NBRV, AGN, JNJ, PFE, ABT, MRK, AMGN.NEWS25: Health Care Sector Update for 06/26/2019: ACST, ABBV, EYEG, NBRV, AGN, JNJ, PFE, ABT, MRK, AMGN.NEWS26: AbbVie to Acquire Allergan in Nearly $62B Cash & Stock Deal.NEWS27: The Zacks Analyst Blog Highlights: AbbVie, Allergan, Bristol-Myers and Celgene.NEWS28: Here&apos;s Why Nobody&apos;s Happy About This $63 Billion Buyout.NEWS29: AbbVie Stock Is Rising as Some See ‘Considerable’ Opportunity in Selloff.NEWS30: AbbVie's Allergan Deal Sets Up Another Trade In Big Biotech.NEWS31: Pre-Market Most Active for Jun 26, 2019 :  HIVE, VICI, PBR, MU, AMD, BB, QQQ, ABBV, NOK, TVIX, TQQQ, SQQQ.NEWS32: Pre-Market Most Active for Jun 26, 2019 :  HIVE, VICI, PBR, MU, AMD, BB, QQQ, ABBV, NOK, TVIX, TQQQ, SQQQ.NEWS33: AbbVie Announces Acquisition of Allergan: What You Should Know.NEWS34: Allergan acquisition is ‘a major bailout’ for shareholders, according to analysts.NEWS35: AbbVie Rises 3%.NEWS36: AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue.NEWS37: Podcast: AbbVie Falls 16% After Merger Announcement.NEWS38: Validea John Neff Strategy Daily Upgrade Report - 6/26/2019.NEWS39: Validea John Neff Strategy Daily Upgrade Report - 6/26/2019.NEWS40: Replay: What to Watch in The Markets: AbbVie-Allergan, Micron, Buffett, and More.NEWS41: 5 Top Stock Trades for Wednesday — AGN, ABBV, FDX, MSFT, BB.NEWS42: Nasdaq Today: Hard to Keep Track of the Losers.NEWS43: Nasdaq Today: Hard to Keep Track of the Losers.
2019-06-27: NEWS1: CORRECTED-US loan market ready to feast on AbbVie's jumbo US$38bn bridge loan.NEWS2: Here’s why drug-distribution and pharmacy stocks are bargains now.NEWS3: Big Pharma Gets Bigger.NEWS4: Big Pharma Gets Bigger.NEWS5: Big Pharma Gets Bigger.NEWS6: AbbVie Rises 3%.NEWS7: Is Allergan a Good Deal for AbbVie?.NEWS8: Is Allergan a Good Deal for AbbVie?.
2019-06-28: NEWS1: After AbbVie Stock Crashed, Three Insiders Loaded Up on Shares.NEWS2: Stock Market Rally Awaits Trump-Xi Outcome; Micron Lifts Chips, Boeing 737 Max Flaw Found.NEWS3: 4 Lower-Risk Healthcare Picks for Long-Term Investors.NEWS4: 4 Lower-Risk Healthcare Picks for Long-Term Investors.NEWS5: 6 Dividend Stocks That Beat the S&P 500.NEWS6: Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger.NEWS7: Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger.NEWS8: Are AbbVie and Allergan Really Better Together?.NEWS9: Are AbbVie and Allergan Really Better Together?.NEWS10: S&P 500 Movers: MKC, STZ.NEWS11: S&P 500 Movers: MKC, STZ.NEWS12: 4 Lower-Risk Healthcare Picks for Long-Term Investors.NEWS13: Are AbbVie and Allergan Really Better Together?.NEWS14: Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger.NEWS15: AbbVie Rises 3%.NEWS16: Almost $500 Billion of Megadeals Get Panned Instantly.
2019-07-01: NEWS1: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS2: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS3: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS4: Notable Monday Option Activity: ABBV, TTWO, MRNS.NEWS5: Notable Monday Option Activity: ABBV, TTWO, MRNS.NEWS6: 7 Stocks on Sale the Insiders Are Buying.NEWS7: 7 Stocks on Sale the Insiders Are Buying.NEWS8: Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval.NEWS9: Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval.NEWS10: Monday 7/1 Insider Buying Report: MDCO, ABBV.NEWS11: Monday 7/1 Insider Buying Report: MDCO, ABBV.NEWS12: Acquisition Improves the Outlook of Pfizer Stock.NEWS13: Acquisition Improves the Outlook of Pfizer Stock.NEWS14: Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval.NEWS15: Acquisition Improves the Outlook of Pfizer Stock.
2019-07-02: NEWS1: Is AbbVie a Buy?.NEWS2: Is AbbVie a Buy?.NEWS3: Is AbbVie a Buy?.NEWS4: Why This Gilead-AbbVie Rivalry Could Come To A Head In 2020.NEWS5: IBM Is Set to Join Exclusive Group of Dividend Aristocrats.NEWS6: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.NEWS7: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.NEWS8: Insiders Buy the Holdings of DLN ETF.NEWS9: Insiders Buy the Holdings of DLN ETF.NEWS10: 3 Biotechs That Have Doubled This Year (Acquisition Next?).NEWS11: 3 Biotechs That Have Doubled This Year (Acquisition Next?).NEWS12: AbbVie’s Allergan Acquisition Sowed Doubts on Wall Street. Some Analysts Are Coming Around..NEWS13: 3 Biotechs That Have Doubled This Year (Acquisition Next?).NEWS14: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.NEWS15: Gilead Surges in the Race for Next Big Anti-Inflammatory Drug.NEWS16: Patent panic gives green light to mega pharma deals.

Answer: Rise